The Th17/IL-17 Axis and Host Defense Against Fungal Infections
- PMID:37116791
- DOI: 10.1016/j.jaip.2023.04.015
The Th17/IL-17 Axis and Host Defense Against Fungal Infections
Abstract
Chronic mucocutaneous candidiasis (CMC) was recognized as a primary immunodeficiency in the early 1970s. However, for almost 40 years, its genetic etiology remained unknown. The progressive molecular and cellular description of inborn errors of immunity (IEI) with syndromic CMC pointed toward a possible role of IL-17-mediated immunity in protecting against fungal infection and CMC. Since 2011, novel IEI affecting either the response to or production of IL-17A and/or IL-17F (IL-17A/F) in patients with isolated or syndromic CMC provided formal proof of the pivotal role of the IL-17 axis in mucocutaneous immunity to Candida spp, and, to a lesser extent, to Staphylococcus aureus in humans. In contrast, IL-17-mediated immunity seems largely redundant against other common microbes in humans. In this review, we outline the current knowledge of IEI associated with impaired IL-17A/F-mediated immunity, highlighting our current understanding of the role of IL-17A/F in human immunity.
Keywords: Anticytokine autoantibodies; Antifungal immunity; Chronic mucocutaneous candidiasis; IL-17 cytokines; Inborn errors of immunity; STATs; Th17 cells.
Copyright © 2023 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
- Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL.Puel A, et al.Science. 2011 Apr 1;332(6025):65-8. doi: 10.1126/science.1200439. Epub 2011 Feb 24.Science. 2011.PMID:21350122Free PMC article.
- Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.Puel A, Cypowyj S, Maródi L, Abel L, Picard C, Casanova JL.Puel A, et al.Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):616-22. doi: 10.1097/ACI.0b013e328358cc0b.Curr Opin Allergy Clin Immunol. 2012.PMID:23026768Free PMC article.Review.
- [CMCD: Chronic Mucocutaneous Candidiasis Disease].Okada S.Okada S.Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(2):109-117. doi: 10.2177/jsci.40.109.Nihon Rinsho Meneki Gakkai Kaishi. 2017.PMID:28603201Review.Japanese.
- Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.Kisand K, Peterson P.Kisand K, et al.Curr Opin Pediatr. 2013 Dec;25(6):715-21. doi: 10.1097/MOP.0000000000000028.Curr Opin Pediatr. 2013.PMID:24240291Review.
- The Evolving View of IL-17-Mediated Immunity in Defense Against Mucocutaneous Candidiasis in Humans.Soltész B, Tóth B, Sarkadi AK, Erdős M, Maródi L.Soltész B, et al.Int Rev Immunol. 2015;34(4):348-63. doi: 10.3109/08830185.2015.1049345.Int Rev Immunol. 2015.PMID:26154078Review.
Cited by
- Card9 and MyD88 differentially regulate Th17 immunity to the commensal yeastMalassezia in the murine skin.Tuor M, Stappers MHT, Ruchti F, Desgardin A, Sparber F, Orr SJ, Gow NAR, LeibundGut-Landmann S.Tuor M, et al.bioRxiv [Preprint]. 2024 Jul 16:2024.07.12.603211. doi: 10.1101/2024.07.12.603211.bioRxiv. 2024.Update in:Mucosal Immunol. 2025 Feb;18(1):205-219. doi: 10.1016/j.mucimm.2024.11.004.PMID:39071334Free PMC article.Updated.Preprint.
- Short-term risk and long-term incidence rate of infection and malignancy with IL-17 and IL-23 inhibitors in adult patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis.Wu S, Xu Y, Yang L, Guo L, Jiang X.Wu S, et al.Front Immunol. 2023 Nov 29;14:1294416. doi: 10.3389/fimmu.2023.1294416. eCollection 2023.Front Immunol. 2023.PMID:38106423Free PMC article.
- Targeting Th17 cells: a promising strategy to treat oral mucosal inflammatory diseases.Wang Y, Xue N, Wang Z, Zeng X, Ji N, Chen Q.Wang Y, et al.Front Immunol. 2023 Jul 26;14:1236856. doi: 10.3389/fimmu.2023.1236856. eCollection 2023.Front Immunol. 2023.PMID:37564654Free PMC article.Review.
- The ouroboros of autoimmunity.Casanova JL, Peel J, Donadieu J, Neehus AL, Puel A, Bastard P.Casanova JL, et al.Nat Immunol. 2024 May;25(5):743-754. doi: 10.1038/s41590-024-01815-y. Epub 2024 May 2.Nat Immunol. 2024.PMID:38698239Review.
- Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology.Cheng KO, Montaño DE, Zelante T, Dietschmann A, Gresnigt MS.Cheng KO, et al.Oxf Open Immunol. 2024 Aug 17;5(1):iqae010. doi: 10.1093/oxfimm/iqae010. eCollection 2024.Oxf Open Immunol. 2024.PMID:39234208Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous